Inhibitors of cyclin-dependent kinases useful for neoplastic diseases and neuronal apoptosis Sep. 20, 1999 No Comments
Oral PEG-1000 formulation of 9-AC studied in phase I/pharmacokinetic solid tumor trial Sep. 20, 1999 No Comments
Abbott designs second-generation farnesyltransferase inhibitors with promising activity Sep. 17, 1999 No Comments
Research at Kyorin leads to potent, nontoxic and water-soluble camptothecin derivative Sep. 17, 1999 No Comments
UroCor and Mallinckrodt enter marketing agreement for brachytherapy implants Sep. 16, 1999 No Comments
New phase I/II data on AE-941/Neovastat in lung cancer presented at ECCO 10 Sep. 15, 1999 No Comments
RSS